Physician
Bend Memorial Clinic PC
Bend Memorial Clinic PC was paid $11.64M by Medicaid between Jan 2018 and Dec 2024, across 187 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 44% of everything it billed.
33Billing provider infoBEND MEMORIAL CLINIC PC
BEND, OR 97701
BEND, OR 97701
33aNPI1699827477assigned 01/18/2007
33bProvider typeInternal Medicine Physician
28Total paid$11.64M
24GClaims284,240
24DCodes billed187
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Oregon
Rank by total paid#2 of 96
Median peer was paid$14K
This provider vs. median831×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,905 | $753K | |
| 2019 | 34,730 | $1.26M | |
| 2020 | 34,042 | $1.23M | |
| 2021 | 46,451 | $1.86M | |
| 2022 | 45,662 | $2.09M | |
| 2023 | 49,262 | $2.21M | |
| 2024incomplete | 49,188 | $2.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44% | 103,027 | 93,723 | $5.11M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 32,241 | 30,194 | $1.42M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.5% | 8,381 | 7,926 | $991K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 5.5% | 600 | 533 | $643K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.8% | 6,579 | 6,155 | $557K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 1,621 | 1,477 | $156K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.3% | 1,695 | 1,506 | $150K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.3% | 1,567 | 1,440 | $148K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.2% | 1,140 | 496 | $136K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 1,586 | 1,347 | $134K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 5,711 | 5,356 | $131K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 3,358 | 3,214 | $127K |
175 more codes
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 4,024 | $114K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,464 | $111K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 3,089 | $96K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,383 | $95K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 544 | $74K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,140 | $74K |
| 93000 | <1% | 6,364 | $66K | |
| 99205 | Prolong outpt/office vis | <1% | 469 | $64K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,302 | $61K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 82 | $59K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 536 | $59K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,163 | $51K |
| 92134 | <1% | 2,992 | $47K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 820 | $43K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 821 | $42K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,124 | $42K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 797 | $41K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 996 | $40K |
| 96415 | <1% | 1,633 | $36K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,936 | $34K |
| 31231 | <1% | 237 | $34K | |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 262 | $30K |
| 92015 | Determination of refractive state | <1% | 3,230 | $29K |
| 80053 | Comprehensive metabolic panel | <1% | 5,431 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,621 | $25K |
| 90686 | <1% | 1,248 | $22K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 369 | $22K |
| 92557 | <1% | 1,162 | $21K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,980 | $21K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 151 | $15K |
| J7999 | Compounded drug, not otherwise classified | <1% | 419 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 769 | $14K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 315 | $13K |
| J2357 | Injection, omalizumab, 5 mg | <1% | 17 | $13K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 125 | $13K |
| 31575 | <1% | 158 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 889 | $12K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,262 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,392 | $11K |
| 76770 | <1% | 315 | $11K | |
| 92567 | <1% | 1,254 | $10K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 278 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 600 | $9K |
| 99223 | Prolong inpt eval add15 m | <1% | 108 | $9K |
| 71250 | <1% | 212 | $9K | |
| 80061 | Lipid panel | <1% | 1,320 | $9K |
| 73630 | <1% | 618 | $9K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 181 | $8K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 179 | $8K |
| 76830 | Ultrasound, transvaginal | <1% | 143 | $7K |
| 11102 | <1% | 103 | $7K | |
| 73130 | <1% | 553 | $7K | |
| 77085 | <1% | 340 | $7K | |
| 92226 | <1% | 999 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 678 | $6K |
| 97803 | <1% | 172 | $6K | |
| 73562 | <1% | 390 | $6K | |
| 94060 | <1% | 176 | $5K | |
| 86140 | <1% | 2,147 | $5K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 41 | $5K |
| 73610 | <1% | 399 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 319 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 231 | $5K |
| 78830 | <1% | 22 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,251 | $5K |
| 73110 | <1% | 291 | $5K | |
| 95251 | <1% | 243 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 121 | $4K |
| 51798 | <1% | 509 | $4K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 47 | $4K |
| 95800 | <1% | 25 | $4K | |
| 94729 | <1% | 123 | $4K | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 179 | $4K |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 147 | $4K |
| 94726 | <1% | 122 | $3K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 35 | $3K |
| 74178 | <1% | 25 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 61 | $3K |
| 90961 | <1% | 123 | $3K | |
| 81002 | <1% | 1,903 | $3K | |
| 0071A | <1% | 76 | $3K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 48 | $3K |
| 80076 | <1% | 664 | $2K | |
| 11721 | <1% | 143 | $2K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 34 | $2K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 36 | $2K |
| 94010 | <1% | 100 | $2K | |
| 17000 | <1% | 66 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 47 | $2K |
| 82565 | <1% | 862 | $2K | |
| 84439 | <1% | 390 | $2K | |
| 73030 | <1% | 170 | $2K | |
| 73140 | <1% | 121 | $2K | |
| 97802 | <1% | 13 | $2K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 35 | $2K |
| 0072A | <1% | 48 | $2K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 64 | $2K |
| 85652 | <1% | 1,304 | $2K | |
| 80069 | <1% | 575 | $2K | |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | <1% | 29 | $2K |
| 80050 | General health panel | <1% | 47 | $1K |
| 0001A | <1% | 149 | $1K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 15 | $1K |
| 77080 | <1% | 82 | $1K | |
| 99152 | <1% | 128 | $1K | |
| 20610 | <1% | 30 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| 51705 | <1% | 50 | $1K | |
| D0191 | <1% | 92 | $1K | |
| 74018 | <1% | 76 | $1K | |
| 92202 | <1% | 250 | $1K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 14 | $1K |
| 99292 | <1% | 20 | $1K | |
| 96160 | <1% | 350 | $1K | |
| 90656 | <1% | 55 | $963.45 | |
| 81015 | <1% | 685 | $914.43 | |
| 95115 | <1% | 130 | $896.10 | |
| 82728 | <1% | 124 | $867.82 | |
| 82607 | <1% | 102 | $827.52 | |
| 0002A | <1% | 66 | $812.80 | |
| 84466 | <1% | 124 | $812.09 | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 13 | $789.97 |
| 96127 | <1% | 122 | $710.98 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 73 | $666.79 |
| 93248 | <1% | 37 | $642.48 | |
| 52000 | <1% | 12 | $612.20 | |
| 99201 | <1% | 17 | $589.56 | |
| 92133 | <1% | 27 | $528.32 | |
| 81003 | <1% | 422 | $526.67 | |
| 92083 | <1% | 12 | $471.39 | |
| 81001 | <1% | 276 | $445.33 | |
| 83540 | <1% | 124 | $411.99 | |
| 83970 | <1% | 26 | $397.60 | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 13 | $367.56 |
| 82043 | <1% | 166 | $360.02 | |
| 72100 | <1% | 32 | $358.02 | |
| 76642 | <1% | 12 | $334.62 | |
| 82570 | <1% | 166 | $322.62 | |
| 99173 | <1% | 109 | $277.16 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 75 | $246.34 |
| 93246 | <1% | 24 | $241.02 | |
| A4550 | Surgical trays | <1% | 376 | $235.27 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $206.42 |
| 90785 | <1% | 12 | $171.01 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $162.18 |
| 73590 | <1% | 15 | $155.10 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 43 | $154.48 |
| 72040 | <1% | 16 | $140.56 | |
| 0296T | <1% | 14 | $135.09 | |
| 85027 | <1% | 32 | $134.94 | |
| 0298T | <1% | 14 | $134.64 | |
| 92285 | <1% | 13 | $124.12 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 44 | $123.21 |
| 99406 | <1% | 14 | $122.79 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 14 | $120.48 |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 26 | $109.30 |
| 99000 | <1% | 41 | $108.90 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 27 | $73.03 |
| 17003 | <1% | 13 | $69.43 | |
| 0011A | <1% | 56 | $62.32 | |
| 81025 | <1% | 12 | $61.05 | |
| 83690 | <1% | 16 | $44.42 | |
| G0008 | Administration of influenza virus vaccine | <1% | 30 | $8.70 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 240 | $6.44 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $4.11 |
| 90662 | <1% | 15 | $1.77 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 59 | $1.48 |
| 91307 | <1% | 167 | $0.01 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 3,098 | $0.00 |
| 91300 | 0% | 224 | $0.00 | |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 27 | $0.00 |
| 91301 | 0% | 56 | $0.00 | |
| D0603 | 0% | 60 | $0.00 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 13 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOVER, JESSIE (CREDENTIALING COORDINATOR)